RLS Protect CIM

RLS Protect CIM (Confidential Information Management) is a platform designed for pharmaceutical organizations that need to identify, review, and redact confidential information across teams and systems. It is aimed at professionals working in Regulatory Affairs, Legal and IP Counsel, Clinical Transparency and Disclosure, Compliance, Clinical, and Medical Affairs functions.

The platform addresses the challenge that confidential information typically spans multiple teams, systems, and document formats. Without a centralized management process and real-time visibility, organizations risk intellectual property (IP) exposure, compliance delays, and regulatory violations. RLS Protect CIM provides a single platform where stakeholders can coordinate the full lifecycle of confidential information management, from initial identification through to redaction and disclosure.

Core Capabilities

• Identifying and categorizing confidential assets across the clinical lifecycle
• Routing confidential information references through multi-stakeholder review and approval workflows
• Detecting potential public domain exposures using keyword and context-based scanning
• Automatically suggesting redactions through integration with RLS Protect Docs

Key Features

• Confidential Asset Tracking: Create and manage confidential information categories to monitor sensitive information from draft through to disclosure
• Approval Workflows: Route confidential information references through automated review and approval flows, with real-time visibility across teams
• Public Domain Scanning: Automatically check sources such as ClinicalTrials.gov for accidental disclosures or exposed confidential information
• AI-Driven Redaction Integration: Synchronizes with RLS Protect Docs so that every reference to confidential information is systematically suggested for redaction in real time
• Audit-Ready Logs: Comprehensive versioning and audit trails to support internal quality assurance processes and Health Authority inquiries

Reported Outcomes

• Fewer cross-functional review cycles through streamlined comment resolution
• Faster redaction and document approvals via automated workflows
• Reduced risk of IP or trade secret exposure to Health Authorities

RLS Protect CIM integrates directly with RLS Protect Docs for redaction functionality and sits within the broader RLS Protect product suite, which also includes anonymization and redaction tools. The platform is designed to support compliance with regulatory frameworks relevant to clinical trial transparency and disclosure.